MUNICH — In patients with left-sided infective endocarditis, a response-tailored antibiotic strategy conferred more time alive without antibiotic therapy compared with standard duration therapy, new data show. For the POET II trial, presented at the European Society of Cardiology Congress and simultaneously published in The New England Journal of Medicine, the researchers randomly assigned

MUNICH — In patients with left-sided infective endocarditis, a response-tailored antibiotic strategy conferred more time alive without antibiotic therapy compared with standard…

A response-tailored strategy reduced antibiotic duration by two weeks without compromising the safety of patients with left-sided infective endocarditis.